Richard Grotjahn and Linlin Pan Dept. of LAWR, Univ. of California, Davis
Deset zapovijedi – δεκα λογοι ( Izl 34,28 Pnz 10,4 )
Sa1236 Antibodies Against Infliximab Are Associated With Increased Risk of Anti-Adalimumab Antibody Development in Patients With Inflammatory Bowel Disease
